Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
Announcements
Projects
Orgs
Project
Post
Articles 187
Votes 2
0% interested
The Lancet
Home
Members
Articles
Authors
1
The Lancet
«
Prev
1
2
3
4
5
6
7
8
Next
»
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts - The Lancet
>2y
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: An explanatory study in Japan - The Lancet
>2y
Rise in group A streptococcal infections in England - The Lancet
>2y
Building on Pasteur's legacy: producing vaccines in Africa - The Lancet
>2y
A new cholinergic mechanism for antipsychotics: emraclidine and M4 muscarinic receptors - The Lancet
>2y
UK cancer care: a watershed moment and the need for urgent intervention - The Lancet
>2y
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative - The Lancet
>2y
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial - The Lancet
>2y
Epidemiology of herpes simplex virus type 2 in Europe: Systematic review, meta-analyses, and meta-regressions - The Lancet
>2y
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation - The Lancet
>2y
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a pr - The Lancet
>2y
Lecanemab for Alzheimer's disease: tempering hype and hope - The Lancet
>2y
Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: A test-negative, case-control study - The Lancet
>2y
Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: Results from a randomised controlled trial - The Lancet
>2y
Is prevention at the heart of UK health policy? - The Lancet
>2y
Matilde Montoya: fighter for women's medical education in Mexico - The Lancet
>2y
John Michael Walshe - The Lancet
>2y
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study - The Lancet
>2y
SABR for primary renal cell carcinoma: single-fraction or multiple-fraction? - The Lancet
>2y
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet
>2y
Integrated pneumonia surveillance: pandemics and beyond - The Lancet
>2y
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study - The Lancet
>2y
Estimating causal effects of physical activity and sedentary behaviours on the development of type 2 diabetes in at-risk children from childhood to late adolescence: an analysis of the QUALITY cohort - The Lancet
>2y
The Advisory Board on Cancer, Infertility and Pregnancy: a virtual on-demand multidisciplinary tumour board - The Lancet
>2y
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery - The Lancet
>2y
«
Prev
1
2
3
4
5
6
7
8
Next
»
Modal title
...
Profile
Loading profile
Loading...